RxDoctor Payments Data

Kathleen Ventry

Adult Health · Niagara Falls, NYNPI 1336376235

Payments from drug & device makers

$2,229in general payments, 2019–2025

Across 117 payments — averaging $19.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boehringer Ingelheim$518
  • Lilly USA, LLC$480
  • Sanofi-aventis U.S. LLC$314
  • Novo Nordisk$172
  • Medtronic$131
  • Dexcom, Inc.$124
  • plus $491 from 14 others

What the payments were for

  • Food & beverage$2,18498%
  • Education$452%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,229 in reported general payments places this provider in the 80th percentile of 3,828 adult health providers in New York.

See all adult health providers in New York

Most prescribed under Part D

DrugClaimsCost to plans & patients
TrulicityDulaglutide224$245,082
JardianceEmpagliflozin102$84,750
OzempicSemaglutide66$64,035
MounjaroTirzepatide42$51,997
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog47$49,443
FarxigaDapagliflozin Propanediol50$48,596
JanuviaSitagliptin Phosphate42$32,787
Humulin R U-500 KwikpenInsulin Regular, Human14$27,263
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog30$20,936
TradjentaLinagliptin19$20,741
Lantus SolostarInsulin Glargine,hum.Rec.Anlog131$19,119
Insulin Lispro Kwikpen U-100Insulin Lispro79$18,878
Humalog Kwikpen U-100Insulin Lispro68$18,049
Tresiba Flextouch U-100Insulin Degludec21$16,731
Omnipod Dash Pods (Gen 4)Insulin Pump Cart,cont Inf,bt23$16,067

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro, Humalog, Insulin Lispro$480$302,198306 claims
Boehringer IngelheimJardiance, Tradjenta, Combivent Respimat$518$112,190133 claims
Novo NordiskOzempic$172$64,03566 claims
AstraZenecaFarxiga$118$48,59650 claims
Johnson & JohnsonInvokana, Xarelto$15$15,55526 claims
Amneal Pharmaceuticals LLCUnithroid, Levothyroxine Sodium$25$3,984188 claims
Sanofi-aventis U.S. LLCLantus$314$1,18114 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 3,828 adult health providers in New York.

Other adult health in Niagara Falls

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →